- Abstract
- 1. Introduction
- 2. Materials and Methods
- 2.1. Template Selection
- 2.2. Model Generation

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
목차 (Table of Contents)
참고문헌 (Reference)
1 C. Colovos, "Verification of protein structures: patterns of nonbonded atomic interactions" 2 : 1511-1519, 1993
2 A. Carotenuto, "Urotensin- II receptor peptide agonists" 24 : 577-588, 2004
3 A. M. D. Watson, "Urotensin II, a novel peptide in central and peripheral cardiovascular control" 25 : 1759-1766, 2004
4 M. Mori, "Urotensin II is the endogenous ligand of a G-proteincoupled orphan receptor, SENR (GPR14)" 265 : 123-129, 1999
5 G. Thanassoulis, "Urotensin II and cardiovascular diseases" 25 : 1789-1794, 2004
6 H. M. Berman, "The protein data bank" 28 : 235-242, 2000
7 K. Totsune, "Role of urotensin II in patients on dialysis" 358 : 810-811, 2001
8 A. M. Richards, "Plasma urotensin II in heart failure" 360 : 545-546, 2002
9 J. J. Maguire, "Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1" 131 : 441-446, 2000
10 W. Kemp, "Increased circulating urotensin II in cirrhosis: potential implications in liver disease" 29 : 868-872, 2008
1 C. Colovos, "Verification of protein structures: patterns of nonbonded atomic interactions" 2 : 1511-1519, 1993
2 A. Carotenuto, "Urotensin- II receptor peptide agonists" 24 : 577-588, 2004
3 A. M. D. Watson, "Urotensin II, a novel peptide in central and peripheral cardiovascular control" 25 : 1759-1766, 2004
4 M. Mori, "Urotensin II is the endogenous ligand of a G-proteincoupled orphan receptor, SENR (GPR14)" 265 : 123-129, 1999
5 G. Thanassoulis, "Urotensin II and cardiovascular diseases" 25 : 1789-1794, 2004
6 H. M. Berman, "The protein data bank" 28 : 235-242, 2000
7 K. Totsune, "Role of urotensin II in patients on dialysis" 358 : 810-811, 2001
8 A. M. Richards, "Plasma urotensin II in heart failure" 360 : 545-546, 2002
9 J. J. Maguire, "Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1" 131 : 441-446, 2000
10 W. Kemp, "Increased circulating urotensin II in cirrhosis: potential implications in liver disease" 29 : 868-872, 2008
11 Q. Liu, "Identification of urotension II as the endogenous ligand for the orphan Gprotein-coupled receptor GPR14" 266 : 174-178, 1999
12 Y. Zhang, "I-TASSER server for protein 3D structure prediction" 9 : 1-8, 2008
13 R. S. Ames, "Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14" 401 : 282-286, 1999
14 K. Takahashi, "Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II" 24 : 301-306, 2003
15 F. D. Russell, "Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure" 285 : 1576-1581, 2003
16 B. K. Kuntal, "Easy Modeller: A graphical interface to Modeller" 3 : 226-, 2010
17 S. A. Douglas, "Congestive heart failure and expression of myocardial urotension II" 359 : 1990-1997, 2002
18 M. Matsushita, "Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues" 19 : 2185-2190, 2001
19 F. D. Russell, "Cardiovascular actions of human urotensin II: considerations for hypertension" 369 : 271-273, 2004
20 S. F. Altschul, "Basic local alignment search tool" 215 : 403-410, 1990
21 S. A. Hollingsworth, "A fresh look at the ramachandran plot and the occurrence of standard structures in proteins" 1 : 271-283, 2010
22 N. Eswar, "A Comparative protein structure modelling with Modeller" 5 : 1-5, 2006
In silico Analysis of Natural Compounds as Modulators of Type I Collagen
Activated Rap1A Induces Osteoblastic Differentiation and Cell Adhesion
Comparative Molecular Similarity Indices Analysis of CXCR-2 Inhibitors
학술지 이력
| 연월일 | 이력구분 | 이력상세 | 등재구분 |
|---|---|---|---|
| 2022 | 평가예정 | 신규평가 신청대상 (신규평가) | |
| 2021-12-01 | 평가 | 등재후보 탈락 (계속평가) | |
| 2020-12-01 | 평가 | 등재후보로 하락 (재인증) | ![]() |
| 2017-01-01 | 평가 | 등재학술지 유지 (계속평가) | ![]() |
| 2013-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | ![]() |
| 2012-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | ![]() |
| 2010-01-01 | 평가 | 등재후보학술지 선정 (신규평가) | ![]() |
학술지 인용정보
| 기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
|---|---|---|---|
| 2016 | 0.45 | 0.45 | 0.35 |
| KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
| 0.28 | 0.25 | 0.24 | 0.05 |